These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1714398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Barriers to fluorescein and protein movement.
    Marmor MF.
    Jpn J Ophthalmol; 1985; 29(2):131-8. PubMed ID: 2413231
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M, Dalgaard P, Lund-Andersen H.
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):350-7. PubMed ID: 1916323
    [Abstract] [Full Text] [Related]

  • 8. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M.
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [Abstract] [Full Text] [Related]

  • 9. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.
    Tan LE, Orilla W, Hughes PM, Tsai S, Burke JA, Wilson CG.
    Invest Ophthalmol Vis Sci; 2011 Feb 25; 52(2):1111-8. PubMed ID: 20881289
    [Abstract] [Full Text] [Related]

  • 10. Fluorescein and fluorescein glucuronide in vitreous: fluorescence and binding properties in vitro.
    Larsen M, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1989 Apr 25; 67(2):137-40. PubMed ID: 2728864
    [Abstract] [Full Text] [Related]

  • 11. The active transport of fluorescein by the retinal vessels and the retina.
    Cunha-Vaz JG, Maurice DM.
    J Physiol; 1967 Aug 25; 191(3):467-86. PubMed ID: 4963870
    [Abstract] [Full Text] [Related]

  • 12. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H, Larsen M, Dalgaard P, Olsen W.
    Graefes Arch Clin Exp Ophthalmol; 1987 Aug 25; 225(3):173-6. PubMed ID: 3609757
    [Abstract] [Full Text] [Related]

  • 13. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y, Tsukahara Y, Saito I, Kondo T.
    Invest Ophthalmol Vis Sci; 1985 Jul 25; 26(7):969-76. PubMed ID: 4008211
    [Abstract] [Full Text] [Related]

  • 14. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE, Chahal PS, Fallon TJ, Cunningham JR, Neal MJ, Kohner EM.
    Exp Eye Res; 1987 Feb 25; 44(2):209-15. PubMed ID: 3582508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Local pressure effects on vitreous kinetics.
    Tsukahara Y, Maurice DM.
    Exp Eye Res; 1995 May 25; 60(5):563-73. PubMed ID: 7615022
    [Abstract] [Full Text] [Related]

  • 17. Finite element modeling of drug distribution in the vitreous humor of the rabbit eye.
    Friedrich S, Cheng YL, Saville B.
    Ann Biomed Eng; 1997 May 25; 25(2):303-14. PubMed ID: 9084836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL, Bernardes RC, Santos FJ, Cunha-Vaz JG.
    Arch Ophthalmol; 1999 May 25; 117(5):631-7. PubMed ID: 10326960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.